Click here if you are having trouble viewing this message.
Cell and Gene Therapy Catapult logo
May newsletter
This month we were delighted to announce £3 million in government investment to drive forward the Life Sciences Industrial Strategy via apprenticeships and skills. This significant scale-up of skills and capability training will bridge the gap between regulatory approval of cell and gene therapies and their integration into front line health services.

This announcement was made at the World Advanced Therapies and Regenerative Medicine Congress in London, where CEO Keith Thompson took the stage in the plenary session and CBO Matthew Durdy chaired the cell and gene C-level forum. 

We are looking forward to taking part in the Automation Special Interest Group in Hertfordshire this week (30-31 May), as well as hosting a networking reception at our newly opened manufacturing centre in Stevenage. More information can be found on our website. 
 
 
News
Major UK investment in skills and capabilities
Cell and Gene Therapy Catapult secured £3 million in government investment to drive forward the Life Sciences Industrial Strategy via apprenticeships and skills.
Press release
World Advanced Therapies & Regenerative Medicine Congress
The message was clear from CGT Catapult at the 13th World Advanced Therapies & Regenerative Medicine Congress on the practical steps that are being taken to upskill professionals to accelerate advanced cell therapies into the clinic.
Find out more
Automation special interest group
We are taking part in the invitation-only group of 150 tasked with creating a roadmap to cost-effective, robust and interconnected manufacturing and supply chain models for commercial scale cell-based therapies.
Event information
Case study: Identifying the price and access potential of novel ATMPs
Are you developing a novel ATMP targeting a rare disease and looking to understand the reimbursed price potential and volume opportunity in the US? Read about our experience on our website.
Read the case study
 
If you have not had a chance to visit the newly opened Cell and Gene Therapy Catapult manufacturing centre in Stevenage, you can now take a virtual tour of the centre in this video. 
 
Upcoming events
Automation SIG
30-31 May 2018
The Grove, Hertfordshire

Dr Stephen Ward, Chief Operating Officer
Review of the key outcomes from SIG 2017 – what’s developed/changed over the past 12 months?

Dr Damian Marshal, Director of Industrialisation
Bioanalytics - What can/should we bring in-process? How to bring it in-process?

More information 
 
Contact us
+44 (0) 203 728 9500
12th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London SE1 9RT